Ohhh and in the original announcement for the debt facility they said about four times we got this debt to ... opportunistically grow the platform. So again it sounds like a plan to get products already ready. The money is in the platform and I think they want to show this off, the benefit of the platform - not so drug development anymore.
BOT Price at posting:
30.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)